Search hospitals > Louisiana > Metairie
East Jefferson General Hospital
Claim this profileMetairie, Louisiana 70006
Global Leader in Prostate Cancer
Global Leader in Lung Cancer
Conducts research for Kidney Cancer
Conducts research for Bladder Cancer
Conducts research for Renal Cell Carcinoma
93 reported clinical trials
11 medical researchers
Summary
East Jefferson General Hospital is a medical facility located in Metairie, Louisiana. This center is recognized for care of Prostate Cancer, Lung Cancer, Kidney Cancer, Bladder Cancer, Renal Cell Carcinoma and other specialties. East Jefferson General Hospital is involved with conducting 93 clinical trials across 226 conditions. There are 11 research doctors associated with this hospital, such as Scott E. Delacroix, Brian C. Boulmay, Augusto C. Ochoa, and Agustin Garcia, M.D..Area of expertise
1Prostate Cancer
Global LeaderStage IV
PD-L1 positive
hCG positive
2Lung Cancer
Global LeaderStage I
Stage II
Stage III
Top PIs
Scott E. DelacroixLSU Healthcare Network / Metairie Multi-Specialty Clinic5 years of reported clinical research
Expert in Prostate Cancer
Studies Bladder Cancer
28 reported clinical trials
63 drugs studied
Brian C. BoulmayUniversity Medical Center New Orleans6 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
19 reported clinical trials
31 drugs studied
Augusto C. OchoaLouisiana State University Health Science Center8 years of reported clinical research
Studies Breast cancer
Studies Breast Cancer
19 reported clinical trials
75 drugs studied
Agustin Garcia, M.D.University Medical Center New Orleans9 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
9 reported clinical trials
18 drugs studied
Clinical Trials running at East Jefferson General Hospital
Prostate Cancer
Kidney Cancer
Bladder Cancer
Ovarian Cancer
Bladder Carcinoma
Lung Cancer
Renal Cell Carcinoma
Uterine Cancer
Cancer
Kidney Carcinoma
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
JNJ-69086420
for Prostate Cancer
The purpose of this study is to determine the recommended Phase 2 dose(s) (RP2D\[s\]) of JNJ-69086420 in Part 1 (Dose Escalation), to determine safety and preliminary signs of clinical activity at the RP2D(s) in Part 2 (Dose Expansion), to determine safety of JNJ-69086420 at the RP2D(s) as a combination therapy in Part 3 (combination therapy) and to determine safety of JNJ-69086420 at the RP2D(s) in participants with metastatic hormone-sensitive prostate cancer (mHSPC) in Part 4.
Recruiting1 award Phase 15 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at East Jefferson General Hospital?
East Jefferson General Hospital is a medical facility located in Metairie, Louisiana. This center is recognized for care of Prostate Cancer, Lung Cancer, Kidney Cancer, Bladder Cancer, Renal Cell Carcinoma and other specialties. East Jefferson General Hospital is involved with conducting 93 clinical trials across 226 conditions. There are 11 research doctors associated with this hospital, such as Scott E. Delacroix, Brian C. Boulmay, Augusto C. Ochoa, and Agustin Garcia, M.D..
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.